Results

Total Results: 1,187 records

Showing results for "week".

161. Having a breast biopsy. A review of the research for women and thier families (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_consumer.pdf
     May 01, 2016 - It takes about a week to get the report. … It can take about a week to get the results.

162. Disposition of Comments for Treatments for Seasonal Allergic Rhinitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_disposition-comments.pdf
     July 17, 2013 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week … be effective with a single pre-treatment administration…would clarify this point or refer to the 2 week … In the Limitations of Review sections in the ES and Full Report, we state: “Our minimum 2-week duration … should be stated again that they are based on as rigorous studies as can be located and with the 2 week … The rationale for the two-week minimum trial duration was explored in discussion with the TEP, and TEP

163. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
     April 01, 2012 - as 2 weeks, and a statistically significant treatment effect was reported to be maintained through week … Also through week 48, investigators reported that patients given ivacaftor were 55% less likely to … second measurement that was 10.6 percentage points higher than patients treated with placebo through week … function were observed as early as 2 weeks, and a significant treatment effect was maintained through week … Also through week 48, patients given ivacaftor were 55% less likely to have a pulmonary exacerbation

164. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
     January 01, 2012 - Patients with severe UC report paying $300–$4,700 for a 10-week dose of pig whipworms ordered from … $485 for three vials, plus shipping. 4 Patients with severe UC report paying $300–$4,700 for a 10-week … Clinical Colitis Activity Index to 57% of baseline, and no adverse events were seen during the 28-week … and/or intravenous fluid volumes) versus 30% of patients (n=43) given placebo (p=0.002). 57 At week … , and 24% of patients reduced their infusion days per week by 3 or more days.

165. Psoriasis-Chronic Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
     November 01, 2012 - with the DLQI.30 Patients with greater PASI responses had greater improvements in DLQI over the 16-week … The mean DLQI change, from baseline to week 16, was significantly greater in the PASI ≥75 group (–9.5 … Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized … treatment on health-related quality of life and other patient- reported outcomes: results from a 16-week

166. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
     May 07, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: May 07, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs) …

167. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
     July 13, 2011 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: July 13, 2011 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Second Generation Antidepressants in the Pharmacologic Treatment of Adult Depression – An Update to a 20…

168. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - and 24% of patients reduced their infusion days per week by 3 or more days. … The mean reduction in PN volume and/or intravenous fluids was 5.2 liters per week from pretreatment … Patients given teduglutide at both dosages experienced a 2.5 liter per week reduction in PN support … versus a 0.9 liter per week reduction for patients given placebo at 24 weeks. … Two patients treated with teduglutide 0.05 mg/kg/day were weaned from PN support by week 24.65 In

169. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - The number needed to treat (NNT) to gain 1 additional responder at week 8 with escitalopram compared

170. Progestogens-Preterm-Birth Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
     September 01, 2012 - 1 Comparative Effectiveness Review Number 74 Progestogens for Prevention of Preterm Birth Executive Summary Introduction Burden of Preterm Birth Birth before completion of 37 weeks of pregnancy is considered preterm. These early births are associated with more than 85 percent of all perinatal morbidity an…

171. Disposition of Comments: CER 230 Therapies for Clinically Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-230-prostate-cancer-comments.pdf
     September 17, 2020 - Each draft report is posted to the EHC Program Web site or AHRQ Web site for public comment for a 3-4-week

172. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
     April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy Evidence-based Practice Center Systematic Review Protocol Project Title: Postpartum Care for Women Up to One Year After Pregnancy Initial Publication Date: February 24, 2022 Amendment Date: April 25, 2022 (Amendments Details-see Section VI…

173. Disposition of Comments Report for Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
     July 10, 2012 - and avoid confusion: “Maximum recommended consumption is 3 or fewer standard drinks per day (7 per week … for men and seven drinks per week for women, and it performed poorly for detecting heavy drinking … ranged from as little as 15 minutes to as long as 6 to 8 hours, full day workshops, or a four week … One RCT reported that counselors completed a four week training in motivational interviewing. … meta-analysis; the reduction in drinks per week was not statistically significant for that study (

174. Disposition of Comments for Progestogens for Prevention of Preterm Birth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
     September 07, 2012 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week

175. Disposition of Comments for CER 208 Treatment for Bipolar Disorder in Adults A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
     August 07, 2018 - At the conclusion of the 3-4-week public comment period, authors use these comments to revise the draft … The document should clarify whether the 3 week, 3 month and 6 month "followup" periods refer to active … Hirshfeld 2004 “Rapid antimanic effect of risperidone monotherapy: A 3‐week multicenter, double‐blind … mania, and their decision thus sits uncomfortably with their decision to include much shorter (3 week

176. Head-Neck-Cancer-Update Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_consumer.pdf
     August 01, 2015 - Radiation Therapy for Head and Neck Cancer A Summary for Adults and Their Caregivers Is This Summary Right for Me? This information may be useful to you if: � Your doctor* said you have head and neck cancer. � Your doctor suggested radiation therapy. If you are not sure if this summary is right for you, a…

177. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0094_04-09-2009.pdf
     January 01, 2009 - effectiveness of lower versus higher “doses” of early behavioral intervention (e.g., 15 versus 25 hours per week

178. Venous-Ulcers-Treatment-Future Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
     January 01, 2014 - part of the stakeholder panel, but they were informed of their ability to comment during the four week

179. Glaucoma-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
     January 01, 2013 - Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week … mean age 61.8 Latanoprost (generic) or Xalatan® qdx6 weeks Mean change in 8AM IOP from baseline to week … 6 Secondary endpoints: mean change at week 2 and in noon and 4PM IOP, safety, tolerability Efficacy … IOP≥24 Age≥18 FC brimonidine-timolol vs. latanoprost x12 weeks Difference in diurnal IOP at week … 12 Efficacy: No differences were seen in mean IOP at week 12 between groups.

180. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - as 2 weeks, and a statistically significant treatment effect was reported to be maintained through week … Also through week 48, investigators reported, patients given ivacaftor were 55% less likely to have … second measurement that was 10.6 percentage points higher than patients treated with placebo through week … function were observed as early as 2 weeks, and a significant treatment effect was maintained through week … Also through week 48, patients given ivacaftor were 55% less likely to have a pulmonary exacerbation